YH12852 0.1 mg + YH12852 0.25 mg + YH12852 0.5 mg + Placebo
Phase 2Terminated 1 views this week 0 watching💤 Quiet
Interest: 27/100
27
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Functional Dyspepsia
Conditions
Functional Dyspepsia
Trial Timeline
Oct 1, 2015 → Mar 16, 2017
NCT ID
NCT02567578About YH12852 0.1 mg + YH12852 0.25 mg + YH12852 0.5 mg + Placebo
YH12852 0.1 mg + YH12852 0.25 mg + YH12852 0.5 mg + Placebo is a phase 2 stage product being developed by Yuhan for Functional Dyspepsia. The current trial status is terminated. This product is registered under clinical trial identifier NCT02567578. Target conditions include Functional Dyspepsia.
What happened to similar drugs?
0 of 6 similar drugs in Functional Dyspepsia were approved
Approved (0) Terminated (1) Active (5)
Hype Score Breakdown
Clinical
12
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02567578 | Phase 2 | Terminated |
Competing Products
20 competing products in Functional Dyspepsia